TECH OUTLOOK 6DECEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comOver the last decade, pharma companies have been implemented tech-driven strategies to gain a steady stream of data that allows them to look at what has happened in the past and try to predict future trends. At the same time, as the demand for personalized medicine grows at a commensurate rate, the pharma and life sciences companies are striving to gain insights from their data streams for the mitigation of prevalent operational challenges. For instance, with a strong data analysis posture, pharma firms can accurately pinpoint the source of inefficiencies that are causing a negative impact on their overall drug development.Presently, as COVID-19 is changing prescribing patterns and the traditional drug and clinical development processes, leading edge pharma analytics is the perfect tool to boost decision-making and build a future that is ready for any sudden shifts in the sector. From a business intelligence (BI) perspective, technology tools will continue doing the heavy lifting for BI perspectives as they help solve organization-specific challenges and de-risk processes that maximize opportunities for human error. As the pharma realm hurtles toward a post-COVID era, the future of pharma analytics remains in the enablement of quicker and safer extraction of insights that can positively impact the overall performance of a pharma company. This edition of Pharma Tech Outlook features a list of leading analytics companies along with insightful articles from thought leaders in the pharma and life sciences analytics arena. We hope the rich industry information included in this edition helps in your business endeavors.Let us know your thoughts.The Future of Drug DiscoveryCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 18 - 2020, Vol 06 - Issue 31 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >